Florian Friedrich

Florian Friedrich

Auto-generated profile, based on publicly available information

Florian Friedrich

Institute of Pharmaceutical Sciences University of Freiburg Albertstr. 25 79104 Freiburg Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ACArianna Colcerasa
Arianna Colcerasa
FFFlorian Friedrich
Florian Friedrich
JMJelena Melesina
Jelena Melesina
PMPatrick Moser
Patrick Moser
AVAnja Vogelmann
Anja Vogelmann
MJManfred Jung
Manfred Jung

4 February 2025 in ChemBioChem
Verified
Journal Article
Open access
MKMarco Kuge
Marco Kuge
MKMichael Keppler
Michael Keppler
FFFlorian Friedrich
Florian Friedrich
RSRaspudin Saleem‐Batcha
Raspudin Saleem‐Batcha
JWJuliana Winter
Juliana Winter
JAJennifer N. Andexer
Jennifer N. Andexer
Polyphosphate kinases (PPK) play crucial roles in various biological processes, including energy storage and stress responses, through their interaction with inorganic polyphosphate (polyP) and the intracellular nucleotide pool. Members of the PPK family 2 (PPK2s) catalyse polyP–consuming phosphorylation of nucleotides. In this study, we characterised two PPK2 enzymes from Bacillus cereus ( Bc PPK2) and Lysinibacillus fusiformis ( Lf PPK2) to investigate their substrate specificity and potential for selective nucleotide synthesis. Both enzymes exhibited a broad substrate scope, selectively converting over 85 % of pyrimidine nucleoside monophosphates (NMPs) to nucleoside diphosphates (NDPs), while nucleoside triphosphate (NTP) formation was observed only with purine NMPs. Preparative enzymatic synthesis of cytidine diphosphate (CDP) was applied to achieve an yield of 49 %. Finally, structural analysis of five crystal structures of Bc PPK2 and Lf PPK2 provided insights into their active sites and substrate interactions. This study highlights PPK2‐II enzymes as promising biocatalysts for the efficient and selective synthesis of pyrimidine NDPs.

13 February 2025 in ACS Catalysis
Verified
Journal Article
Open access
FGFerdinand Genz
Ferdinand Genz
FFFlorian Friedrich
Florian Friedrich
Christoph LoenarzChristoph Loenarz
Christoph Loenarz
OEOliver Einsle
Oliver Einsle
MJManfred Jung
Manfred Jung
NFNico Dennis Fessner
Nico Dennis Fessner

20 May 2025 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
FFFlorian Friedrich
Florian Friedrich
MSMatthias Schiedel
Matthias Schiedel
SSSören Swyter
Sören Swyter
LZLin Zhang
Lin Zhang
Wolfgang SipplWolfgang Sippl
Wolfgang Sippl
MJManfred Jung
Manfred Jung
The selectivity pocket is a key binding site for inhibitors of the NAD+-dependent lysine deacylase Sirtuin 2 (Sirt2), a promising drug target in diseases like cancer. While small-molecule soaking can advance inhibitor development, the selectivity pocket is absent in available Sirt2 apo structures, and existing soaking systems like Sirt2-ADPribose (ADPR) suffer from unfavorable crystal packing that hinders ligand binding. We developed a method to rapidly generate high-quality Sirt2 apo crystals with an open selectivity pocket, suitable for high-throughput soaking. The induced-fit pocket forms upon seeding with a Sirtuin Rearranging ligand (SirReal) and is retained in the ligand-free apo structure. Screening the Maybridge Ro3-fragment library using a fluorescence polarization assay yielded three novel Sirt2-fragment-inhibitor structures. Additionally, our Sirt2 apo crystals can accommodate ligands at the acyl-lysine channel entrance and the cofactor binding site, as confirmed by binding of the peptide inhibitor KT9 and NAD+, facilitating SAR studies and inhibitor optimization.

8 July 2025 in Nucleic Acids Research
Verified
Journal Article
Open access
LPLaura Pulido-Cortés
Laura Pulido-Cortés
HGHajo Gielingh
Hajo Gielingh
VTVito Thijssen
Vito Thijssen
MLMinglong Liu
Minglong Liu
RYRyoji Yoshisada
Ryoji Yoshisada
MTMarc Timmers
Marc Timmers
Post-translational modifications of histone tails constitute a key epigenetic mechanism controlling chromatin environment and gene transcription. Serotonylation of histone H3Q5 (H3Q5ser) is a recently discovered mark associated with active transcription of RNA polymerase II (pol II)-transcribed genes. The direct link between H3Q5ser and the pol II transcription machinery relies on the TFIID subunit TAF3. The presence of H3Q5ser enhances TAF3 binding to H3K4me3, but the molecular determinants underlying this interaction remained unclear. Here, we resolve the binding mode of TAF3-PHD to H3K4me3Q5ser identifying a novel binding surface for H3Q5ser using solution nuclear magnetic resonance spectroscopy. This reveals how H3Q5ser recognizes a conserved surface of the TAF3-PHD via CH–π interactions in an edge–face conformation involving a proline residue stabilized by a tryptophan. This combination of proline and tryptophan is unique to the PHD finger of TAF3 and conserved among TAF3 orthologues. Our findings establish a framework for the molecular recognition of serotonylated chromatin, laying the foundation for developing epigenetic inhibitors targeting serotonylation-dependent transcriptional regulation in neuronal development.

19 August 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
RWRicky Wirawan
Ricky Wirawan
MFMatthias Frei
Matthias Frei
AHAnna Heider
Anna Heider
NPNiklas Papenkordt
Niklas Papenkordt
FFFlorian Friedrich
Florian Friedrich
Franz BracherFranz Bracher
Franz Bracher
The duality of halogen-bonding-mediated ligand stabilization and the inteference of NAD + co-factor binding represents an effective strategy in the development of highly potent SIRT2 inhibitors.